Three forces are stranding the legacy REDD+ pipeline and concentrating value in a handful of ARR specialists. A field guide to who wins, who disappears, and what disciplines define survival to 2028.
All three matured 2024–2025. Together they are not incremental — they are a structural shift.
01
Methodology
Verra VM0048 + ICVCM Core Carbon Principle labels strand the legacy REDD+ project pipeline. Older methods (VM0006/0007/0009/0015/0037) phase out — never submitted for CCP.
Issuance 131Mt → 10Mt (4 years)
02
Demand
Hyperscaler ARR offtake at USD 30–100/t. Microsoft, Google, Meta, Salesforce, McKinsey, Bain via Symbiosis Coalition. Native-species removal credits are the only premium-priced product.
Symbiosis: >20Mt by 2030
03
Regulation + safeguards
Brazil's SBCE under Law 15.042/2024. CONAREDD+ Resolution 19/2025. MPF, FUNAI, Federal Police interventions make indigenous and traditional-community FPIC the controlling due-diligence variable.
Resolution 19/2025: codified May 2025
03 / 25
Macro Pillar 1
Brazil's SBCE — the regulated market arrives.
Law 15.042 (11 Dec 2024). Cap-and-trade above 25,000 tCO₂e/yr. First allowance auction expected late 2028.
5-phase rollout through ~2030. Reporting threshold 10,000 tCO₂e/yr.
Decree 12,677 (16 Oct 2025): Extraordinary Secretariat for Carbon Market under Ministry of Finance.
Decree 12,678: Department of Market Instruments + REDD+ under Ministry of Environment.
Most credible Brazilian-headquartered ARR pure-play. Public-concession first-mover. Bom Futuro is a template — Forest Service has 3.2M more ha potentially available.
11 / 25
Tier 1 Profile · Founder-Led Tech-Buyer Favourite
Mombak
Pará native-species reforestation · Google's sole forestry supplier
Ascendant
Founders: Peter Fernandez (CEO, ex-Nubank/99), Gabriel Haddad Silva (CFO, ex-Nubank/99). São Paulo, founded 2021.
Industrial planting model: ~1,700 native seedlings/ha on degraded Pará pasture. Flagship: Turmalina (Mãe do Rio).
~20,000 ha across 4 sites. ~5M trees planted; 8M target mid-2025.
Series A USD 30M (Apr 2025, USV-led; Bain Capital, Kaszek, AXA IM Alts, Lowercarbon, Copa).
BNDES R$160M 2025 — first reforestation deal under R$10B Climate Fund.
Google COP30 200k t deal — largest CDR contract Google has ever signed.
First Symbiosis Coalition project selected from 185 vetted globally.
$329M
cumulative incl. outcome bonds (CB Insights)
$50–100/t
credit pricing achieved
$150M+
offtake contracted
1 / 185
Symbiosis selection rate
Strategic positioning
Highest-profile pure-play. Industrial planting criticised on cost. Flight-to-quality buyers value verifiability over per-ha cost. Watch for IPO 2027–28.
~1.6–2M ha. Shell USD 38M strategic stake (2022). Fortaleza Ituxi/Unitor/Evergreen suspended by Verra. R$28.8M IBAMA fines on partners. Soil-carbon diversification underway.
Biofílica Ambipar Parent solvency
Ambipar Participações in judicial recovery
Filed 20 Oct 2025; approved 4 Nov; parallel US Chapter 11. Trigger: derivatives on 10.875% green notes 2031. ~2.5M ha conserved (Vale do Jari, RESEX Jacundá, Juruá, Ateles).
Permian Global Legacy drag
Pacajaí Verra-suspended Sept 2023
BeZero + Sylvera negative on Pacajaí. Newer work (Resex Rio Cautário, RMDLT Portel, Recaatingamento Caatinga) holds technical credibility. Distancing strategy.
Wildlife Works / Everland FPIC
Alto Turiaçu suspended by Brazilian federal judge
Ka'apor injunction June 2025. Indigenous Amazon Outcome Bond w/ BNP Paribas (USD 50M, USD 160M LOIs by Nov 2025). Equitable Earth Standard. Brazilian footprint still aspirational.
14 / 25
The Crowded Middle
Mid-tier landscape: four strategic choices.
Defining choice in next 12 months. Most likely outcome: 30–50% wind down or get acquired by 2027.
Three shifts compounding. An insured + vertically integrated + multi-eligible credit at scale = highest-priced asset in the market.
A
Insurance
Kita (Lloyd's; Chaucer, Munich Re Specialty, RenRe, Tokio Marine Kiln, MS Amlin). Buffer Depletion Protection live with Wilder Carbon. Plus Oka, Howden/Respira/Aon, CFC, Arbol, We2Sure, CarbonPool.
Forward offtake anchor — Symbiosis member or BNDES / Petrobras ProFloresta+ allocation.
7
R$200–250M+ patient capital + best-in-class scientific team. The bar is high precisely because the prize is unprecedented: $50–100/credit, multi-year contracts, public-concession optionality.
25 / 25
Closing Thesis
Capital, buyers, regulators, indigenous federations converging on the same answer.
Developers meeting that combination consolidate gains. Developers not meeting it are acquired, restructured, or quietly wound down. There is no middle path forming.
Brazil & Amazon NbS Carbon · Field Guide · v.05.2026